Joe Whalen, Senior Vice President, Business Development and Alliance Management at Horizon Pharma
Horizon Pharma Logo

Joe Whalen


Senior Vice President, Business Development and Alliance Management
Horizon Pharma

Check out the incredible speaker line-up to see who will be joining Joe.

Download The Latest Agenda

The Latest Trends in Biopharma Partnering

Thursday, January 5th, 2017


09:00 Therapeutic Focus Area Ice Breaker Roundtables

Kick-start your partnering experience meeting those who prioritize the same therapeutic areas as you! Find out the latest priorities in the biggest therapeutic areas and current opportunities available. Discuss goals, common industry challenges and firm up your personal partnering objectives for the next three days.

#1 Oncology
Todd Haim, Program Director, NIH, National Cancer Institute, Small Business Innovation Research (SBIR) Development Center

#2 Immunology

Kia Motesharei, Head, Global Licensing & Business Development, Immunology, Merck KGaA, Darmstadt, Germany

#3 Immuno-oncology

Paul Resnick, Vice President and Chief Business Officer, MabVax Therapeutics, Inc.

#4 Rare and Orphan Diseases
Joe Whalen, Senior Vice President, Business Development & Alliance Management, Horizon Pharma

#5 Pain
Kathryn Gregory, Executive Director, Business Development, Purdue Pharma

#6 Gene Therapy
Jeremy Ahouse, Executive Director, Business Development & Global Alliances, Celgene

#7 Diabetes
Christoph Pittius, Vice President, Head of Transactions, AstraZeneca

#8
Neurodegenerative Diseases

14:00 Panel Discussion | The Equities Market of 2016, What is Possible?

• Where can you find money in public markets currently?
• What creative financing is being done?
• How are companies finding money to launch?